| Cat.No. | Name | Information |
|---|---|---|
| M31297 | WKYMVM acetate | WKYMVM acetate is a potent agonist of the N-formyl peptide receptors FPR1 and FPRL1/2, and also activates a number of leukocyte effector functions such as chemotaxis, activation of complement receptor-3 and NADPH oxidase. |
| M31296 | Trp-Lys-Tyr-Met-Val-Met-NH2 | Trp-Lys-Tyr-Met-Val-Met-NH2 (WKYMVm) is a synthetic peptide that is also a specific agonist for formyl peptide-like receptor 1 (FPRL1). |
| M10897 | Randialic acid B | Randialic acid B is a triterpenoid compound that is a formyl peptide receptor 1 (FPR1) antagonist. Randialic acid B blocks FPR1 in human neutrophils and reduces psoriasis-like inflammation in vivo. |
| M10538 | N-Boc-Phe-Leu-Phe-Leu-Phe (Boc2) | N-Boc-Phe-Leu-Phe-Leu-Phe (Boc2) is a nonselective N-formyl peptide receptor (FPR) antagonist. |
| M10468 | N-Formyl-Met-Leu-Phe | N-Formyl-Met-Leu-Phe (fMLP) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR), which can inhibit TNF-alpha secretion. |
| M10451 | WRW4 | WRW4 is a selective antagonist of formyl peptide receptor 1 (FPR1) signaling, it inhibits WKYMVm binding to FPR1 (IC50 = 0.23 μM). |
| M10147 | WKYMVM TFA | WKYMVM TFA is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist. |
| M9875 | ACT-389949 | ACT-389949 is a first-in-class, potent, selective formyl peptide receptor 2/lipoprotein A4 receptor (FPR2)/(ALX) agonist with an EC50 value of 3 nM for FPR2/ALX entry into monocytes.Additionally, ACT-389949 is an excellent tool compound for in vitro and in vivo to further analyze FPR2-regulated activity, which could be used in the development of next-generation FPR signaling-regulated anti-inflammatory therapies. |
| M9845 | PBP10 TFA salt | PBP10 is a 10-AA peptide with rhodamine conjugated at its N terminus, exerts bactericidal activity against gram-positive and gram-negative bacteria and limits microbial-induced inflammatory effects. |
| M7370 | TC-FPR 43 | TC-FPR 43 is a potent FPR2 agonist. |
| M54382 | Ac9-25 | Ac9-25, a N-terminal peptide of Annexin I, acts as a formyl peptide receptor (FPR) agonist and activates the neutrophil NADPH oxidase through FPR. |
| M54317 | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist. |
| M54247 | WKYMVM-NH2 TFA | WKYMVM-NH2 TFA is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist, also activates several leukocyte effector functions. |
| M53962 | {Boc}-Phe-Leu-Phe-Leu-Phe | {Boc}-Phe-Leu-Phe-Leu-Phe ({Boc}-FLFLF) is a formyl peptide receptor (FPR) family antagonist that preferentially inhibits activity triggered through the formyl peptide receptor. |
| M53908 | WKYMVM | WKYMVM is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist, also activates several leukocyte effector functions such as chemotaxis, mobilization of complement receptor-3, and activation of the NADPH oxidase. |
| M53185 | N-Formyl-Met-Leu-Phe-Lys | N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively. |
| M53184 | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist. |
| M53183 | MMK1 | MMK1 is a potent and selective human formyl peptide receptor like-1 (FPRL-1/FPR2) agonist with EC50s of <2 nM and >10000 nM for FPRL-1 and FPR1, respectively. |
| M41820 | WRW4-OH | WRW4-OH is a biological active peptide. |
| M21272 | BMS-986235 | BMS-986235/LAR-1219 is an FPR1-sparing FPR2-selective agonist designed to help address chronic inflammation/promote wound healing to prevent serious complications such as heart failure. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
